Cardiovascular Financial Statements From 2010 to 2025

CVSCDelisted Stock  USD 0.0001  0.00  0.00%   
Cardiovascular Sciences' financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Cardiovascular Sciences' valuation are provided below:
Cardiovascular Sciences does not presently have any fundamental signals for analysis.
Check Cardiovascular Sciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Cardiovascular Sciences' main balance sheet or income statement drivers, such as , as well as many indicators such as . Cardiovascular financial statements analysis is a perfect complement when working with Cardiovascular Sciences Valuation or Volatility modules.
  
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.

Cardiovascular Sciences Company Shares Outstanding Analysis

Cardiovascular Sciences' Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.

Shares Outstanding

 = 

Public Shares

-

Repurchased

More About Shares Outstanding | All Equity Analysis

Current Cardiovascular Sciences Shares Outstanding

    
  16.96 M  
Most of Cardiovascular Sciences' fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Cardiovascular Sciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
Competition

Based on the latest financial disclosure, Cardiovascular Sciences has 16.96 M of shares currently outstending. This is much higher than that of the Health Care Equipment & Supplies sector and significantly higher than that of the Health Care industry. The shares outstanding for all United States stocks is notably lower than that of the firm.

Cardiovascular Sciences Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Cardiovascular Sciences's current stock value. Our valuation model uses many indicators to compare Cardiovascular Sciences value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Cardiovascular Sciences competition to find correlations between indicators driving Cardiovascular Sciences's intrinsic value. More Info.
Cardiovascular Sciences is number one stock in profit margin category among its peers. It also is number one stock in operating margin category among its peers reporting about  0.21  of Operating Margin per Profit Margin. The ratio of Profit Margin to Operating Margin for Cardiovascular Sciences is roughly  4.76 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Cardiovascular Sciences' earnings, one of the primary drivers of an investment's value.

About Cardiovascular Sciences Financial Statements

Cardiovascular Sciences stakeholders use historical fundamental indicators, such as Cardiovascular Sciences' revenue or net income, to determine how well the company is positioned to perform in the future. Although Cardiovascular Sciences investors may analyze each financial statement separately, they are all interrelated. For example, changes in Cardiovascular Sciences' assets and liabilities are reflected in the revenues and expenses on Cardiovascular Sciences' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Cardiovascular Sciences. Please read more on our technical analysis and fundamental analysis pages.
Cardiovascular Sciences Inc., a technology company, focuses on the development of medical products. The company was formerly known as Beverly Hills Weight Loss and Wellness, Inc. and changed its name to Cardiovascular Sciences, Inc. in May 2006. Cardiovascular Sci is traded on OTC Exchange in the United States.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.
You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..

Other Consideration for investing in Cardiovascular Stock

If you are still planning to invest in Cardiovascular Sciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Cardiovascular Sciences' history and understand the potential risks before investing.
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Commodity Directory
Find actively traded commodities issued by global exchanges
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
FinTech Suite
Use AI to screen and filter profitable investment opportunities